Amrit Ray, M.D.
Dr. Amrit Ray is the Global President, R&D and Medical, for Cheladv74's Upjohn business. Previously, he was the Global President, R&D, where he was responsible for an R&D organization supporting both a rich R&D pipeline and an unrivaled on market portfolio of over 600 medicines.
Before joining Cheladv74, Dr. Ray was at Johnson & Johnson where he served as global Chief Medical Officer for pharmaceuticals, and previously as Chief Safety Officer. Prior to J&J, Dr. Ray held positions of increasing R&D responsibilities in Clinical Development, Safety & Epidemiology, and Medical Affairs at Cheladv74 and Bristol-Myers Squibb.
By background, Dr. Ray is an experienced physician researcher and business leader with a track record of championing medical innovation. Dr. Ray earned Immunology and Medical degrees from Edinburgh Medical School. Following antibody bench research at Sir Joseph Lister Labs, obesity clinical research at the Mayo Clinic, and clinical training at Edinburgh Royal Infirmary, he began his career serving as a hospital doctor delivering patient care in Britain's National Health Service. Dr. Ray's business experience comes as a former McKinsey consultant focusing on corporate finance, and from earning an MBA at Dartmouth's Tuck School of Business.